Bdparib 300 Tablet
Marketer
BDR Pharmaceuticals Internationals Pvt
Salt Composition
Rucaparib (300mg)
Overview Bdparib 300 Tablet
Olaparib 300mg tablets are indicated for the management of prostate and ovarian cancers. Its mechanism involves inhibiting the repair of damaged cancerous cells, thereby halting their proliferation and inducing cell death. Olaparib 300mg tablets may be administered with or without food, but consistent daily timing is recommended. Dosage and frequency are determined by your physician, based on your specific condition and may be adjusted. Strict adherence to the prescribed regimen is crucial; improper usage or overdose can lead to severe adverse reactions. Therapeutic effects might not be apparent for weeks or months; discontinue only under medical supervision. Frequently reported side effects encompass elevated liver enzymes, reduced appetite, anemia, fatigue, gastrointestinal discomfort, acute myeloid leukemia, and nasopharyngitis. Report fever, chills, pharyngitis, or severe diarrhea to your doctor immediately. Regular blood tests monitoring blood cell counts, hepatic and renal function, and uric acid levels are necessary. Adequate hydration is advised to mitigate diarrhea. Prior to commencing treatment, disclose any pre-existing cardiac, hepatic, or renal conditions, and all concurrent medications, including antibiotics, to your physician. Significant drug interactions are possible. This medication is contraindicated during pregnancy and lactation; effective contraception for both partners is essential throughout treatment.
Primary Ingredients of Bdparib 300 Tablet
The information is unavailable.
Uses of Bdparib 300 Tablet
Malignancies of the prostate and ovaries
Major Benefits of Bdparib 300 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 300mg Bdparib tablet whole; avoid chewing, crushing, or breaking it. While this medication can be taken with or without food, consistent timing is recommended.
Common Side effects of Bdparib 300 Tablet:
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Rash
- Increased liver enzymes
- Decreased appetite
- Anemia (low number of red blood cells)
- Weakness
- Gastrointestinal disturbance
- Myelodysplastic syndrome
- Acute myeloid leukemia (blood cancer)
How to use Bdparib 300 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 300mg Bdparib tablet whole; avoid chewing, crushing, or fracturing it. While food is optional, consistent timing is recommended.
How Bdparib 300 Tablet works:
By inhibiting specific proteins, the 300mg Bdparib tablet hinders DNA repair in cancer cells, leading to their demise.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Bdparib 300 Tablet may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Bdparib 300 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Bdparib 300 Tablet while breastfeeding is likely inadvisable. Available human data indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Bdparib 300 Tablet on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Bdparib 300 mg tablets can be administered to patients with renal impairment without modification of the prescribed dosage.
LiverSAFE IF PRESCRIBED
Bdparib 300mg tablets can be administered to patients with hepatic impairment without modification of the prescribed dosage.
What if you forget to take Bdparib 300 Tablet :
NA
Facts to Know About Bdparib 300 Tablet
| Label | Value |
|---|---|
| Type of Compound | Indoles bearing a phenyl substituent at the 2-position |
| Potential for Dependence | None. |
| Type of Treatment | Cancer-fighting drugs |
3,018 People bought this recently
